相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer et al.
NATURE REVIEWS GENETICS (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Cancer transcriptome profiling at the juncture of clinical translation
Marcin Cieslik et al.
NATURE REVIEWS GENETICS (2018)
Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing
Henry Rodriguez et al.
CELL (2018)
Evaluation of NCI-7 Cell Line Panel as a Reference Material for Clinical Proteomics
David J. Clark et al.
JOURNAL OF PROTEOME RESEARCH (2018)
A large-scale and robust dynamic MRM study of colorectal cancer biomarkers
Jia You et al.
JOURNAL OF PROTEOMICS (2018)
Integrative omics for health and disease
Konrad J. Karczewski et al.
NATURE REVIEWS GENETICS (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
Zbyslaw Sondka et al.
NATURE REVIEWS CANCER (2018)
The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy
Fatima Ardito et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
EGFR-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine: Importance of Germline EGFR T790M Testing
Ammar Sukari et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Abseq: Ultrahigh-throughput single cell protein profiling with droplet microfluidic barcoding
Payam Shahi et al.
SCIENTIFIC REPORTS (2017)
Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer
Carl A. K. Borrebaeck
NATURE REVIEWS CANCER (2017)
Comprehensive analysis of protein glycosylation by solid-phase extraction of N-linked glycans and glycosite-containing peptides
Shisheng Sun et al.
NATURE BIOTECHNOLOGY (2016)
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Hui Zhang et al.
CELL (2016)
The Role of Next-Generation Sequencing in Enabling Personalized Oncology Therapy
C. A. Cummings et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2016)
Mission critical: the need for proteomics in the era of next-generation sequencing and precision medicine
Devon M. Cayer et al.
HUMAN MOLECULAR GENETICS (2016)
Proteogenomics connects somatic mutations to signalling in breast cancer
Philipp Mertins et al.
NATURE (2016)
Coming of age: ten years of next-generation sequencing technologies
Sara Goodwin et al.
NATURE REVIEWS GENETICS (2016)
Advances in mass spectrometry-based clinical biomarker discovery
Christopher A. Crutchfield et al.
CLINICAL PROTEOMICS (2016)
Translating clinical proteomics: the importance of study design
Evelyne Maes et al.
EXPERT REVIEW OF PROTEOMICS (2015)
Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma
Wei Jiang et al.
MOLECULAR CANCER THERAPEUTICS (2015)
AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer
Pasi A. Jaenne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A New Initiative on Precision Medicine
Francis S. Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics
Alan Kirwan et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?
Veronique G. LeBlanc et al.
CANCERS (2015)
Revealing the Complexity of Breast Cancer by Next Generation Sequencing
John Verigos et al.
CANCERS (2015)
Glycosylation in cancer: mechanisms and clinical implications
Salome S. Pinho et al.
NATURE REVIEWS CANCER (2015)
NEXT GENERATION SEQUENCING IN CANCER RESEARCH AND CLINICAL APPLICATION
Derek Shyr et al.
OMICS IN CLINICAL PRACTICE: GENOMICS, PHARMACOGENOMICS, PROTEOMICS, AND TRANSCRIPTOMICS IN CLINICAL RESEARCH (2014)
Epigenetic biomarkers in lung cancer
Triantafillos Liloglou et al.
CANCER LETTERS (2014)
Biomarker discovery of nasopharyngeal carcinoma by proteomics
Liang Xiao et al.
EXPERT REVIEW OF PROTEOMICS (2014)
Proteomic cancer biomarkers from discovery to approval: it's worth the effort
Danni Li et al.
EXPERT REVIEW OF PROTEOMICS (2014)
Targeting HER2 in ovarian and uterine cancers: Challenges and future directions
Eleonora Teplinsky et al.
GYNECOLOGIC ONCOLOGY (2014)
Metabolomics in cancer biomarker discovery: Current trends and future perspectives
Emily G. Armitage et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Proteogenomic characterization of human colon and rectal cancer
Bing Zhang et al.
NATURE (2014)
Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins
Jacob J. Kennedy et al.
NATURE METHODS (2014)
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Thomas F. Imperiale et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cancer Cell Profiling by Barcoding Allows Multiplexed Protein Analysis in Fine-Needle Aspirates
Adeeti V. Ullal et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Diagnostic Cancer Genome Sequencing and the Contribution of Germline Variants
O. Kilpivaara et al.
SCIENCE (2013)
Next generation sequencing in cancer research and clinical application
Derek Shyr et al.
BIOLOGICAL PROCEDURES ONLINE (2013)
Human Genome Sequencing in Health and Disease
Claudia Gonzaga-Jauregui et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Beyond Diagnostic Accuracy: The Clinical Utility of Diagnostic Tests
Patrick M. M. Bossuyt et al.
CLINICAL CHEMISTRY (2012)
Quantifying the Added Value of a Diagnostic Test or Marker
Karel G. M. Moons et al.
CLINICAL CHEMISTRY (2012)
HECT and RING finger families of E3 ubiquitin ligases at a glance
Meredith B. Metzger et al.
JOURNAL OF CELL SCIENCE (2012)
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
Christine Vogel et al.
NATURE REVIEWS GENETICS (2012)
The Predictive Capacity of Personal Genome Sequencing
Nicholas J. Roberts et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
New paradigms in translational science research in cancer biomarkers
Paul D. Wagner et al.
TRANSLATIONAL RESEARCH (2012)
Selected reaction monitoring for quantitative proteomics: a tutorial
Vinzenz Lange et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
Analytical validation of the oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer
Maureen Cronin et al.
CLINICAL CHEMISTRY (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Ubiquitin ligases: cell-cycle control and cancer
KI Nakayama et al.
NATURE REVIEWS CANCER (2006)
Review - Mass spectrometry and protein analysis
B Domon et al.
SCIENCE (2006)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Z Zhang et al.
CANCER RESEARCH (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents
PL Ross et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer
EM John et al.
BREAST CANCER RESEARCH (2004)
Tandem mass tags:: A novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS
A Thompson et al.
ANALYTICAL CHEMISTRY (2003)
Proteomic analysis of post-translational modifications
M Mann et al.
NATURE BIOTECHNOLOGY (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics
SE Ong et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Cancer susceptibility and the functions of BRCA1 and BRCA2
AR Venkitaraman
CELL (2002)
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation
R Hashizume et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
